730 / 1544
ESTRO IMRT Course, May 2013
And most recently……
ELIOT
(Veronesi, Lancet Oncol, 2013)
No significant difference in secondary cancers
at median F/U of
5 years
Uppsala Örebrö
(Wickberg, JCO, 2014)
5% (contral. Breast cancer) and 2% (any cancer)
absolute difference after
20 Years
Prime II
(Kunkler et al., SA-Breast Cancer 2013)
No signisficant) difference in secondary cancers
at median F/U of
5 years
(>65Y)